Marco Manfredini
Overview
Explore the profile of Marco Manfredini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Manfredini M, Sticchi A, Lippolis N, Pedroni G, Giovani M, Ciardo S, et al.
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510902
The evaluation of acne-prone skin and absent-to-mild acne is difficult because this condition is not associated with a clinically definable situation. Previous studies showed that apparently healthy skin in patients...
12.
Guida S, Longo C, Amato S, Rossi A, Manfredini M, Ciardo S, et al.
Medicina (Kaunas)
. 2023 Jun;
59(6).
PMID: 37374244
Laser treatments have become popular in Dermatology. In parallel to technologic development enabling the availability of different laser wavelengths, non-invasive skin imaging techniques, such as reflectance confocal microscopy (RCM), have...
13.
Guida S, Alma A, Fiorito F, Megna A, Chester J, Kaleci S, et al.
J Eur Acad Dermatol Venereol
. 2023 Jun;
37(11):2293-2300.
PMID: 37357442
Introduction: Dermoscopic predictors of lentigo maligna (LM) and lentigo maligna melanoma (LMM) have been recently reported, but these have not been reported in reflectance confocal microscopy (RCM). Objectives: (i) To...
14.
Bardazzi F, Viviani F, Piraccini B, Lasagni C, Bigi L, Manfredini M, et al.
J Cutan Med Surg
. 2023 Mar;
27(2):126-132.
PMID: 36995351
Background: IL-23 inhibitors are the latest class of biologic drugs approved for moderate-to-severe psoriasis. Objectives: to investigate real-life safety and efficacy of tildrakizumab. Methods: demographic data, medical history, psoriasis disease...
15.
Pezzini C, Ciardo S, Guida S, Kaleci S, Chester J, Casari A, et al.
Exp Dermatol
. 2022 Nov;
32(4):348-358.
PMID: 36394180
Few studies have combined high-resolution, non-invasive imaging, such as standardized clinical images, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT), for age-related skin change characterization according to age groups....
16.
Manfredini M, Alma A, Pongetti L, Sticchi A, Baschieri E, Farnetani F, et al.
Dermatol Ther
. 2022 Sep;
35(11):e15837.
PMID: 36114750
No abstract available.
17.
Guida S, Alma A, Shaniko K, Chester J, Ciardo S, Proietti I, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740502
Background/objectives: Non-melanoma skin cancer (NMSC) treated with nonsurgical therapies can be monitored with noninvasive skin imaging. The precision of dermoscopy, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) in...
18.
Alma A, Sticchi A, Chello C, Guida S, Farnetani F, Chester J, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407391
Noninvasive imaging techniques have recently outlined precise microscopic features of acne elementary lesions and accurate quantifications for disease severity staging and therapeutical efficacy follow-up. The aim of this review is...
19.
Manfredini M, Chello C, Ciardo S, Guida S, Chester J, Lasagni C, et al.
Exp Dermatol
. 2022 Mar;
31(7):1076-1082.
PMID: 35263469
Hidradenitis suppurativa (HS) is an inflammatory disease characterized by a recurrent-remission trend and clinical lesions that range from asymptomatic to inflamed, deep-seated nodules with scarring and suppuration. The aim of...
20.
Guida S, Lippolis N, Giovani M, Pedroni G, Urtis G, Pellacani G, et al.
Dermatol Pract Concept
. 2022 Feb;
12(1):e2022024.
PMID: 35223169
No abstract available.